News, views and contacts from the global Pharmaceutical industry
28 July 2017
Industry News

Eisai seeks marketing authorisation for lenvatinib from EMA
Eisai has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for first-line use of lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC).

Deals this week: Fidson Healthcare, Sarepta Therapeutics, North China Pharmaceutical
Nigerian pharmaceutical company Fidson Healthcare plans to raise NGN6bn ($18.65m) through a rights offering of shares.

AstraZeneca’s faslodex receives EU approval for advanced breast cancer treatment
The European Commission (EC) has approved AstraZeneca’s faslodex (fulvestrant) for the treatment of oestrogen-receptor positive, locally advanced or metastatic breast cancer in postmenopausal women not previously treated with endocrine therapy.

ViiV reaches another milestone
On July 24, 2017, ViiV Healthcare announced positive results from 96-week data obtained from a Phase IIb, open-label study (LATTE-2) investigating the safety and efficacy of a two-drug, long-acting injectable anti-HIV formulation composed of ViiV’s cabotegravir and Janssen’s Edurant (rilpivirine).

Press Releases

CAR-T Acknowledged by FDA Committee
Novartis has announced its CAR-T cell therapy CTL019 has been recommended by the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC).

Zenith Technologies Seeks New Engineers
Worldwide system integration company Zenith Technologies is currently looking to take on new engineers.

Atlant Clinical to Become a Gold Sponsor for YJP Life Science & Healthcare Conferences
Atlant Clinical has become a sponsor for regular Life Science & Healthcare conferences organised by YJP.

New Transmitters Now Available with RS-485 Communication
ROTRONIC's BF2 series of measurement transmitters, BF220 process pressure transmitter, and the BF227 are available with RS-485 communication.

HOF Awarded TOP 100 Label
HOF has announced that is has received the TOP 100 label, which ranks among the top 100 most innovative companies in Germany.

White Papers

Dry Powder Inhaler Monodose RS01
Patented, manufactured, and marketed by Plastiape, the RS01 Monodose Dry Powder Inhaler has a refined piercing unit design, which required the study of new manufacturing techniques and a...

Addressing Serialisation Challenges to Achieve Business Benefits and Best Practice Deployment in the Pharmaceutical Sector
With EU and US serialisation deadlines coming closer, companies are realising the benefits of track and...

Dispelling the Myths of Deviation and CAPA Systems
'How to Simplify for Improve your Deviation and CAPA Systems' is one of NSF's most popular in-house courses. The company provides simple tools and techniques that dramatically improve...

Skrivanek Pharmaceuticals References
Skrivanek has established long-term relationships for more than 20 years with some of the world's most respected pharmaceutical companies and publish health...

Crystallisation and Filtration Brochure
Systag's crystallisation and filtration system helps increase your flexibility, productivity, and optimises your...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties. is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.